Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice-Reference-Cited by-同舟云学术

Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice

Published:2018-03-22 Issue:3 Volume:10 Page:386-401
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Weiss Roxanne¹²,Fernandez Elizabeth¹²,Liu Yuhong²,Strong Randy¹²³,Salmon Adam B.¹²⁴

Affiliation:

1. Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care System, San Antonio, TX 78294, USA

2. The Sam and Ann Barshop Institute for Longevity and Aging Studies, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA

3. Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA

4. Department of Molecular Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. eNODAL: an experimentally guided nutriomics data clustering method to unravel complex drug-diet interactions;2023-10-04

2. Combinatorial interventions in aging;Nature Aging;2023-10-02

3. Metformin protects against pulmonary hypertension-induced right ventricular dysfunction in an age- and sex-specific manner independent of cardiac AMPK;American Journal of Physiology-Heart and Circulatory Physiology;2023-08-01

4. Mechanisms of ageing: growth hormone, dietary restriction, and metformin;The Lancet Diabetes & Endocrinology;2023-04

5. Sweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post‐transplant diabetes mellitus and type 2 diabetes mellitus after kidney transplantation;Clinical Transplantation;2023-02-13